BWXT (BWXT) Q4 2025 Earnings Call Transcript

The Motley Fool

by newsfeedback@fool.com (Motley Fool Transcribing)

February 24, 2026

AI-Generated Deep Dive Summary

BWXT (BWXT) delivered record-breaking performance in its Q4 2025 earnings call, showcasing strong revenue growth, profitability, and strategic expansion across both government and commercial operations. Total revenue surged 19% year over year to $886 million for the quarter, with full-year revenue reaching a company high of $3.4 billion, up 18%. Adjusted EBITDA rose 13% to $148 million for the quarter and is projected to range between $645 million to $660 million in 2026, reflecting low to mid-teens growth. Notably, adjusted earnings per share (EPS) jumped 17% to $1.08, driven by robust operating performance and a modest contribution from non-operating items. The company’s commercial operations segment demonstrated exceptional momentum, with revenue surging 95% year over year, including 31% organic growth. Segment adjusted EBITDA reached $44 million, up 87%, supported by strong demand for medical isotopes and actinium sales through BWXT Medical. The segment also secured significant new contracts, including U.S. defense uranium enrichment and high-purity depleted uranium production, further solidifying its position in the commercial market. BWXT highlighted key strategic initiatives and investments, such as the completion of a $1.25 billion convertible debt transaction to refinance existing debt at improved terms. The company also emphasized its progress in advancing microreactor fuel technology, including the delivery of the first core TRISO fuel for Project Pele and ongoing production for the ANTARES reactor. Additionally, BWXT’s expansion into new facilities, such as the Innovation Campus and Digital Center, underscores its commitment to innovation and long-term growth. Looking ahead, BWXT provided 2026 guidance with revenue expected at approximately $3.75 billion, representing high teens growth. The company anticipates Commercial Operations segment revenue to grow by 25%, while non-GAAP EPS is projected to range between $4.55 and $4.70, reflecting mid to high teens growth. Free cash flow guidance for the year is set at $305 million to $320 million,

Verticals

financeinvesting

Originally published on The Motley Fool on 2/24/2026